158 related articles for article (PubMed ID: 33591255)
1. [Rethinking the place of B lymphocyte and tertiary lymphoid structures in oncoimmunotherapy].
Germain C; Kaplon H; Dieu-Nosjean MC
Med Sci (Paris); 2021 Feb; 37(2):130-133. PubMed ID: 33591255
[No Abstract] [Full Text] [Related]
2. [Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses].
Fridman WH; Petitprez F; Sautes-Fridman C
Bull Cancer; 2020 Apr; 107(4):403-404. PubMed ID: 32284150
[No Abstract] [Full Text] [Related]
3. Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer.
Sautès-Fridman C; Verneau J; Sun CM; Moreira M; Chen TW; Meylan M; Petitprez F; Fridman WH
Semin Immunol; 2020 Apr; 48():101406. PubMed ID: 33248905
[TBL] [Abstract][Full Text] [Related]
4. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
Tang H; Qiu X; Timmerman C; Fu YX
Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
[TBL] [Abstract][Full Text] [Related]
5. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
[TBL] [Abstract][Full Text] [Related]
6. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
7. CD86
Wennhold K; Thelen M; Lehmann J; Schran S; Preugszat E; Garcia-Marquez M; Lechner A; Shimabukuro-Vornhagen A; Ercanoglu MS; Klein F; Thangarajah F; Eidt S; Löser H; Bruns C; Quaas A; von Bergwelt-Baildon M; Schlößer HA
Cancer Immunol Res; 2021 Sep; 9(9):1098-1108. PubMed ID: 34155067
[TBL] [Abstract][Full Text] [Related]
8. Tertiary Lymphoid Structures: Autoimmunity Goes Local.
Pipi E; Nayar S; Gardner DH; Colafrancesco S; Smith C; Barone F
Front Immunol; 2018; 9():1952. PubMed ID: 30258435
[TBL] [Abstract][Full Text] [Related]
9. In vitro testing in tumor immunotherapy.
Berkelhammer J
Semin Oncol; 1974 Dec; 1(4):397-408. PubMed ID: 4143489
[No Abstract] [Full Text] [Related]
10. Neglected no more: B cell-mediated anti-tumor immunity.
Conejo-Garcia JR; Biswas S; Chaurio R; Rodriguez PC
Semin Immunol; 2023 Jan; 65():101707. PubMed ID: 36527759
[TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
[TBL] [Abstract][Full Text] [Related]
12. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
[TBL] [Abstract][Full Text] [Related]
13. Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.
Seow DYB; Yeong JPS; Lim JX; Chia N; Lim JCT; Ong CCH; Tan PH; Iqbal J
Breast Cancer Res Treat; 2020 Apr; 180(2):369-377. PubMed ID: 32034580
[TBL] [Abstract][Full Text] [Related]
14. B cells and tertiary lymphoid structures promote immunotherapy response.
Helmink BA; Reddy SM; Gao J; Zhang S; Basar R; Thakur R; Yizhak K; Sade-Feldman M; Blando J; Han G; Gopalakrishnan V; Xi Y; Zhao H; Amaria RN; Tawbi HA; Cogdill AP; Liu W; LeBleu VS; Kugeratski FG; Patel S; Davies MA; Hwu P; Lee JE; Gershenwald JE; Lucci A; Arora R; Woodman S; Keung EZ; Gaudreau PO; Reuben A; Spencer CN; Burton EM; Haydu LE; Lazar AJ; Zapassodi R; Hudgens CW; Ledesma DA; Ong S; Bailey M; Warren S; Rao D; Krijgsman O; Rozeman EA; Peeper D; Blank CU; Schumacher TN; Butterfield LH; Zelazowska MA; McBride KM; Kalluri R; Allison J; Petitprez F; Fridman WH; Sautès-Fridman C; Hacohen N; Rezvani K; Sharma P; Tetzlaff MT; Wang L; Wargo JA
Nature; 2020 Jan; 577(7791):549-555. PubMed ID: 31942075
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.
Kroeger DR; Milne K; Nelson BH
Clin Cancer Res; 2016 Jun; 22(12):3005-15. PubMed ID: 26763251
[TBL] [Abstract][Full Text] [Related]
16. Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma.
van de Walle T; Vaccaro A; Ramachandran M; Pietilä I; Essand M; Dimberg A
Front Immunol; 2021; 12():724739. PubMed ID: 34539661
[TBL] [Abstract][Full Text] [Related]
17. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
Vella G; Guelfi S; Bergers G
Front Immunol; 2021; 12():736670. PubMed ID: 34484246
[TBL] [Abstract][Full Text] [Related]
18. Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy.
Xu W; Yang J; Ye S; Liu W; Lu J; Anwaier A; Zhang H; Ye D
Immunotherapy; 2024 Feb; 16(3):131-134. PubMed ID: 38112020
[No Abstract] [Full Text] [Related]
19. B cells in the formation of tertiary lymphoid organs in autoimmunity, transplantation and tumorigenesis.
Corsiero E; Delvecchio FR; Bombardieri M; Pitzalis C
Curr Opin Immunol; 2019 Apr; 57():46-52. PubMed ID: 30798069
[TBL] [Abstract][Full Text] [Related]
20. Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.
Kang W; Feng Z; Luo J; He Z; Liu J; Wu J; Rong P
Front Immunol; 2021; 12():689270. PubMed ID: 34394083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
